Cart
sales@molnova.com
Ryuvidine
CAS No. 265312-55-8
Ryuvidine( SPS8I-2 )
Catalog No. M13813 CAS No. 265312-55-8
Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 141 | In Stock |
|
| 10MG | 207 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 511 | In Stock |
|
| 100MG | 728 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRyuvidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRyuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
-
DescriptionRyuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM); shows potent cytototoxic activity against HL-60, A549, Col 1, HepG2 cancer cell lines with IC50 of 0.3-1.2 ug/mL; also inhibits SETD8 with IC50 of 0.5 uM, efficiently and selectively suppresses cellular H4K20me1 at doses lower than 5 uM.
-
In Vitro——
-
In Vivo——
-
SynonymsSPS8I-2
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number265312-55-8
-
Formula Weight284.3
-
Molecular FormulaC15H12N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NC2=C(C(C=C(NC3=CC=C(C)C=C3)C2=O)=O)S1
-
Chemical Name2-methyl-5-[(4-methylphenyl)amino]-4,7-benzothiazoledione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blum G, et al. ACS Chem Biol. 2014 Nov 21;9(11):2471-8.
2. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4.
3. Lang E, et al. Cell Physiol Biochem. 2015;37(3):1178-86.
molnova catalog
related products
-
VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
-
THZ1 2HCl
THZ1 2HCl is a selective, covalent, and allosteric inhibitor of CDK7 with an IC50 of 3.2 nM. THZ1 2HCl has antiproliferative effects on a variety of cancer cell lines.
-
DprE1-IN-1
DprE1-IN-1 is a potent inhibitor of DprE1 and PDE6.
